Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems ... delivering the NovaSeq X single-flow-cell system alongside a cutting-edge software upgrade and new kits.

Sequencing was performed on an Illumina MiSeq System using paired-end 150 bp reads and following Illumina’s protocol using the MiSeq Reagent Micro Kit, V.2. The median coverage was 90×. Variants were ...

The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing ...

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train ...

SAN DIEGO and CHICAGO - Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM) today announced a partnership aimed at advancing the use of artificial intelligence (AI) in genomic ...

Illumina Inc. and Tempus AI ... With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision ...

(RTTNews) - Illumina Inc. (ILMN) and Tempus AI, Inc. (TEM), Tuesday announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation.

Bernstein lowered the firm’s price target on Illumina (ILMN) to $90 from $130 and keeps a Market Perform rating on the shares. With tariffs, concerns about NIH and broader academic/government ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Gain precise, in-depth insights into microbial genomes with Illumina’s comprehensive Methods for Microbial Single-Genome Sequencing guide.

Let’s take a look at how Illumina (NASDAQ:ILMN) and the rest of the life sciences tools & services stocks fared in Q4. Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM), a ...